BridgeBio to Attend Investor Conferences in November
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 03 2025
0mins
Should l Buy ?
Source: Globenewswire
Fireside Chats Announcement: BridgeBio Pharma will host fireside chats at the UBS Global Healthcare Conference on November 10 and the Jefferies Global Healthcare Conference on November 18, 2025.
Webcast Access: Live webcasts of the presentations can be accessed on the BridgeBio website, with replays available for 90 days post-event.
Company Overview: BridgeBio Pharma, founded in 2015, focuses on developing transformative medicines for genetic diseases, with a pipeline that includes early science to advanced clinical trials.
Contact Information: Media and investor contacts for BridgeBio are provided, including names, roles, and email addresses for inquiries.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
